Published in Radiology on May 05, 2008
Microwave tissue ablation: biophysics, technology, and applications. Crit Rev Biomed Eng (2010) 1.34
Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation. J Vasc Interv Radiol (2012) 1.33
Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology (2010) 1.07
Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour. Eur Radiol (2010) 0.88
A New Scheme for Curved Needle Segmentation in Three-Dimensional Ultrasound Images. Proc IEEE Int Symp Biomed Imaging (2009) 0.83
Ablative therapies for renal tumors. Ther Adv Urol (2010) 0.77
Is radiofrequency ablation more cost-effective than nephron-sparing surgery for small unilateral renal cell carcinoma? Nat Clin Pract Urol (2008) 0.75
Percutaneous ablation of functioning adenoma in a patient with a single adrenal gland. BMJ Case Rep (2013) 0.75
Radiofrequency ablation: a minimally invasive approach in kidney tumor management. Cancers (Basel) (2010) 0.75
Decision Making: Thermal Ablation Options for Small Renal Masses. Semin Intervent Radiol (2017) 0.75
Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA (1996) 14.23
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst (2006) 6.58
Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making (2000) 4.86
The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making (1993) 4.46
Medicare and cost-effectiveness analysis. N Engl J Med (2005) 4.20
Medicare coverage for technological innovations--time for new criteria? N Engl J Med (2004) 3.84
Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst (1995) 3.81
Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol (2001) 3.65
The Markov process in medical prognosis. Med Decis Making (1983) 3.58
Increased incidence of serendipitously discovered renal cell carcinoma. Urology (1998) 3.35
A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med (1982) 2.56
Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol (2005) 2.53
A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med (1982) 2.49
Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol (2007) 2.20
Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation. Med Decis Making (2005) 2.10
Effects of perfusion on radiofrequency ablation in swine kidneys. Radiology (2004) 2.07
Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making (2002) 1.78
Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol (2005) 1.55
Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol (1996) 1.47
Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol (2005) 1.34
Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol (2004) 1.31
Utility valuations for outcome states of colorectal cancer. Am J Gastroenterol (1999) 1.30
Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol (2000) 1.26
Cost-effectiveness in a flat world--can ICDs help the United States get rhythm? N Engl J Med (2005) 1.24
Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol (2005) 1.15
Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol (2003) 1.14
Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology (1995) 1.13
Comparison of the descriptive epidemiology of urinary tract cancers. Cancer Causes Control (1990) 1.11
Comparison of costs and complications of radical and partial nephrectomy for treatment of localized renal cell carcinoma. Urology (2002) 1.07
Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy. J Urol (1995) 1.03
Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Intervent Radiol (2007) 1.01
Outcome of laparoscopic radical and open partial nephrectomy for the sporadic 4 cm. or less renal tumor with a normal contralateral kidney. J Urol (2002) 0.96
Willingness to pay for a QALY: theoretical and methodological issues. Pharmacoeconomics (2005) 0.94
Assessment of health-related quality of life after radiofrequency ablation or laparoscopic surgery for small renal cell carcinoma: a prospective study with medical outcomes Study 36-Item Health Survey (SF-36). Jpn J Clin Oncol (2007) 0.94
Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection. Radiology (2004) 0.94
Evolution of surgical technique and patient outcomes for laparoscopic partial nephrectomy. Urology (2006) 0.94
Renal cryotherapy: a detailed review including a 5-year follow-up. BJU Int (2007) 0.93
Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience. Cardiovasc Intervent Radiol (2006) 0.93
Nephron-sparing surgery for renal cell carcinoma. Annu Rev Med (2002) 0.91
Radiofrequency ablation of renal cell carcinoma. Abdom Imaging (2005) 0.87
Which is the real gold standard for small-volume renal tumors? Radical nephrectomy versus nephron-sparing surgery. J Endourol (2004) 0.85
Ablative techniques for the management of kidney cancer. Nat Clin Pract Urol (2007) 0.83
Radiofrequency ablation of renal tumors: past, present, and future. Urology (2005) 0.83
A cost comparison of nephron-sparing surgical techniques for renal tumour. BJU Int (2005) 0.77
Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology (2003) 5.42
Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med (2012) 4.72
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA (2004) 4.36
Adult intestinal intussusception: CT appearances and identification of a causative lead point. Radiographics (2006) 3.22
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology (2005) 3.01
Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol (2006) 2.88
Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol (2011) 2.83
Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clin Gastroenterol Hepatol (2008) 2.74
Urine leaks and urinomas: diagnosis and imaging-guided intervention. Radiographics (2003) 2.73
Paraesophageal hernias: operation or observation? Ann Surg (2002) 2.71
Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol (2012) 2.66
Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst (2004) 2.53
Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol (2005) 2.53
Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology (2003) 2.53
Acute epiploic appendagitis and its mimics. Radiographics (2005) 2.46
CT appearance of acute appendagitis. AJR Am J Roentgenol (2004) 2.39
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology (2008) 2.37
Autoimmune pancreatitis: imaging features. Radiology (2004) 2.34
Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst (2012) 2.30
Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 2.29
Clinical practice. Small renal mass. N Engl J Med (2010) 2.27
Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg (2006) 2.25
Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer (2003) 2.22
Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology (2013) 2.13
Dropped appendicolith: CT findings and implications for management. AJR Am J Roentgenol (2008) 2.03
Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology (2005) 1.91
Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. Radiology (2007) 1.87
Pheochromocytoma: an imaging chameleon. Radiographics (2004) 1.84
Transgluteal approach for percutaneous drainage of deep pelvic abscesses: 154 cases. Radiology (2003) 1.78
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology (2014) 1.78
Image-guided percutaneous splenic interventions. Radiographics (2012) 1.73
Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology (2003) 1.69
Incidence of malignancy in complex cystic renal masses (Bosniak category III): should imaging-guided biopsy precede surgery? AJR Am J Roentgenol (2003) 1.68
Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients. AJR Am J Roentgenol (2009) 1.68
The IR RadLex project: an interventional radiology lexicon--a collaborative project of the Radiological Society of North America and the Society of Interventional Radiology. J Vasc Interv Radiol (2008) 1.61
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology (2012) 1.58
Impact of obesity on medical imaging and image-guided intervention. AJR Am J Roentgenol (2007) 1.58
Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol (2008) 1.57
Abdominopelvic CT increases diagnostic certainty and guides management decisions: a prospective investigation of 584 patients in a large academic medical center. AJR Am J Roentgenol (2011) 1.56
Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Ann Thorac Surg (2008) 1.56
Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med (2012) 1.52
Reorganizing the system of care surrounding laparoscopic surgery: a cost-effectiveness analysis using discrete-event simulation. Med Decis Making (2004) 1.51
Percutaneous ablation in the kidney. Radiology (2011) 1.51
Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics (2009) 1.48
Incidence and predictors of adenocarcinoma following endoscopic ablation of Barrett's esophagus. Dig Dis Sci (2014) 1.44
Extraadrenal pheochromocytoma: a rare cause of tachycardia and hypertension during percutaneous biopsy. AJR Am J Roentgenol (2005) 1.44
Percutaneous lung biopsy in a patient with a cavitating lung mass: indications, technique, and complications. AJR Am J Roentgenol (2005) 1.44
Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol (2008) 1.42
Rare benign and malignant appendiceal lesions: spectrum of computed tomography findings with pathologic correlation. J Comput Assist Tomogr (2003) 1.38
Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain. AJR Am J Roentgenol (2008) 1.37
CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics (2011) 1.36
Algorithmic approach to CT diagnosis of the abnormal bowel wall. Radiographics (2002) 1.36
A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. J Card Fail (2006) 1.36
Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol (2005) 1.34
Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain. J Am Coll Cardiol (2009) 1.34
Percutaneous hepatic abscess drainage: do multiple abscesses or multiloculated abscesses preclude drainage or affect outcome? J Vasc Interv Radiol (2009) 1.34
Imaging diagnosis of cystic pancreatic lesions: pseudocyst versus nonpseudocyst. Radiographics (2005) 1.32
Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions. AJR Am J Roentgenol (2008) 1.28
Calibration of disease simulation model using an engineering approach. Value Health (2009) 1.27
Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer (2008) 1.26
Cost-effectiveness of whole-body CT screening. Radiology (2005) 1.25
Utility estimates for decision-analytic modeling in chronic heart failure--health states based on New York Heart Association classes and number of rehospitalizations. Value Health (2008) 1.24
Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol (2006) 1.23
Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value Health (2011) 1.22
Effect of obesity on image quality: fifteen-year longitudinal study for evaluation of dictated radiology reports. Radiology (2006) 1.22
Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Proc Natl Acad Sci U S A (2010) 1.20
MR imaging of the acute abdomen and pelvis: acute appendicitis and beyond. Radiographics (2007) 1.20
Radiation dose reduction with hybrid iterative reconstruction for pediatric CT. Radiology (2012) 1.19
Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol (2009) 1.18
Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience. Radiology (2006) 1.17
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2007) 1.16
Cystic lymph node metastases in papillary thyroid carcinoma. AJR Am J Roentgenol (2002) 1.16
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 1.16
Percutaneous abscess drainage in Crohn disease: technical success and short- and long-term outcomes during 14 years. Radiology (2002) 1.15
Celiac plexus block: a palliative tool underused by radiologists. AJR Am J Roentgenol (2002) 1.15
Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol (2005) 1.15
Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis. Med Decis Making (2006) 1.14
Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology (2002) 1.14
Bowel hot spots at PET-CT. Radiographics (2007) 1.14
Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it. AJR Am J Roentgenol (2009) 1.13
Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis. Radiology (2008) 1.13
Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer (2014) 1.13
Diagnostic imaging costs: are they driving up the costs of hospital care? Radiology (2005) 1.11
Long-term acceptance of renal allografts following prenatal inoculation with adult bone marrow. Transplantation (2005) 1.11